Showing results (51-60 of 756) with videos related to

Sort By:
Pageof 76
The Lancet. Infectious Diseases|August 28, 2022
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agentsNorberto Perico, Monica Cortinovis, Fredy Suter, et al.
Contributions to Nephrology|August 3, 2021
COVID-19 and the Kidney: Should Nephrologists Care about COVID-19 rather than Maintaining Their Focus on Renal Patients?Norberto Perico, Luca Perico, Claudio Ronco, et al.
Nature Reviews. Nephrology|September 19, 2018
Maternal and environmental risk factors for neonatal AKI and its long-term consequencesNorberto Perico, David Askenazi, Monica Cortinovis, et al.
Nephron|May 18, 2026
Immunosuppressive strategies in kidney xenotransplantation with an emphasis on complement inhibitionFederica Casiraghi, Nadia Azzollini, Giuseppe Remuzzi, et al.
International Journal of Hypertension|December 20, 2012
Prevalence of hypertension and diabetes and coexistence of chronic kidney disease and cardiovascular risk in the population of the republic of moldovaIgor Codreanu, Vera Sali, Sergiu Gaibu, et al.
Lancet (London, England)|November 16, 2004
Delayed graft function in kidney transplantationNorberto Perico, Dario Cattaneo, Mohamed H Sayegh, et al.
Nature Reviews. Nephrology|April 2, 2022
Glomerular hyperfiltrationMonica Cortinovis, Norberto Perico, Piero Ruggenenti, et al.
Kidney International|August 8, 2002
Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantationDario Cattaneo, Norberto Perico, Flavio Gaspari, et al.
Personalized Medicine|May 26, 2018
Pharmacogenetics and pharmacogenomics of immunosuppressive agents: perspective for individualized therapyDario Cattaneo, Anna Tankiewicz, Simona Merlini, et al.
Pediatric Nephrology (Berlin, Germany)|October 6, 2016
Achieving remission of proteinuria in childhood CKDPiero Ruggenenti, Paolo Cravedi, Antonietta Chianca, et al.
Pageof 76